Verition Fund Management
ABVX

Verition Fund Management’s Abivax ABVX Stock Holding History

Verition Fund Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$579K Buy
+5,200
New +$615K ﹤0.01% 1536

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Verition Fund Management's ABVX Position: Q1 2026 in Review

Verition Fund Management reduced its Abivax (ABVX) stake by 58% in Q1 2026, selling an estimated $4.19M and leaving 25,948 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #833.

Verition Fund Management first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.27M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Verition Fund Management held 25,948 shares of Abivax worth $2.89M as of Q1 2026.
  • Verition Fund Management sold 35,369 Abivax shares in Q1 2026, an estimated $4.19M.
  • Abivax made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #833 holding.
  • Verition Fund Management first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Verition Fund Management's Abivax position peaked at $8.27M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.